CDK Global (CDK) Tops Q4 EPS by 2c, Offers FY19 Guidance
CDK Global (NASDAQ: CDK) reported Q4 EPS of $0.87, $0.02 better than the analyst estimate of $0.85. Revenue for the quarter came in at $569.2 million versus the consensus estimate of $578.99 million.
GUIDANCE:
CDK Global sees FY2019 EPS of $3.85-$3.95, versus the consensus of $4.11.
| Fiscal 2019 Guidance | |
| Revenues | up (1.0%) - 1.0% |
| Diluted earnings attributable to | $3.20 - $3.30 |
| CDK per share | up 15.0% - 19.0% |
| Adjusted diluted earnings attributable to | $3.85 - $3.95 |
| CDK per share | up 15.0% - 18.0% |
| Net earnings attributable to CDK | up 6.0% - 10.0% |
| Margin | 17.5% - 18.5% |
| Adjusted EBITDA | up 8.0% - 12.0% |
| Margin | 39.0% - 40.0% |
For earnings history and earnings-related data on CDK Global (CDK) click here.